205 related articles for article (PubMed ID: 26150544)
1. Metabolic Dysregulation Induced in Plasmodium falciparum by Dihydroartemisinin and Other Front-Line Antimalarial Drugs.
Cobbold SA; Chua HH; Nijagal B; Creek DJ; Ralph SA; McConville MJ
J Infect Dis; 2016 Jan; 213(2):276-86. PubMed ID: 26150544
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.
Wojnarski M; Mouri O; Chambrion C; Roussel C; Chartrel N; Smith B; Smith P; Thellier M; Buffet P; Ndour PA
J Infect Dis; 2019 Jul; 220(3):535-539. PubMed ID: 30877300
[TBL] [Abstract][Full Text] [Related]
3. New antimalarial drugs.
Wiesner J; Ortmann R; Jomaa H; Schlitzer M
Angew Chem Int Ed Engl; 2003 Nov; 42(43):5274-93. PubMed ID: 14613157
[TBL] [Abstract][Full Text] [Related]
4. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
5. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
[TBL] [Abstract][Full Text] [Related]
6. Assessment of in vitro antimalarial interactions between dihydroartemisinin and fosmidomycin.
Chaijaroenkul W; Pruktal P; Muhamad P; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):791-5. PubMed ID: 18041293
[TBL] [Abstract][Full Text] [Related]
7. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
[TBL] [Abstract][Full Text] [Related]
9. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
Fivelman QL; Adagu IS; Warhurst DC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4097-102. PubMed ID: 15504827
[TBL] [Abstract][Full Text] [Related]
10. The Redox Cycler Plasmodione Is a Fast-Acting Antimalarial Lead Compound with Pronounced Activity against Sexual and Early Asexual Blood-Stage Parasites.
Ehrhardt K; Deregnaucourt C; Goetz AA; Tzanova T; Gallo V; Arese P; Pradines B; Adjalley SH; Bagrel D; Blandin S; Lanzer M; Davioud-Charvet E
Antimicrob Agents Chemother; 2016 Sep; 60(9):5146-58. PubMed ID: 27297478
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics-Based Screening of the Malaria Box Reveals both Novel and Established Mechanisms of Action.
Creek DJ; Chua HH; Cobbold SA; Nijagal B; MacRae JI; Dickerman BK; Gilson PR; Ralph SA; McConville MJ
Antimicrob Agents Chemother; 2016 Nov; 60(11):6650-6663. PubMed ID: 27572396
[TBL] [Abstract][Full Text] [Related]
12. Determining the Mode of Action of Antimalarial Drugs Using Time-Resolved LC-MS-Based Metabolite Profiling.
Cobbold SA; McConville MJ
Methods Mol Biol; 2019; 1859():225-239. PubMed ID: 30421232
[TBL] [Abstract][Full Text] [Related]
13. The antimalarial activities of methylene blue and the 1,4-naphthoquinone 3-[4-(trifluoromethyl)benzyl]-menadione are not due to inhibition of the mitochondrial electron transport chain.
Ehrhardt K; Davioud-Charvet E; Ke H; Vaidya AB; Lanzer M; Deponte M
Antimicrob Agents Chemother; 2013 May; 57(5):2114-20. PubMed ID: 23439633
[TBL] [Abstract][Full Text] [Related]
14. Combining Stage Specificity and Metabolomic Profiling to Advance Antimalarial Drug Discovery.
Murithi JM; Owen ES; Istvan ES; Lee MCS; Ottilie S; Chibale K; Goldberg DE; Winzeler EA; Llinás M; Fidock DA; Vanaerschot M
Cell Chem Biol; 2020 Feb; 27(2):158-171.e3. PubMed ID: 31813848
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives.
Basco LK; Le Bras J
Ann Trop Med Parasitol; 1994 Apr; 88(2):137-44. PubMed ID: 8067809
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 4-aminoquinoline-containing antimalarial drugs on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes.
Famin O; Ginsburg H
Biochem Pharmacol; 2002 Feb; 63(3):393-8. PubMed ID: 11853690
[TBL] [Abstract][Full Text] [Related]
17. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
[TBL] [Abstract][Full Text] [Related]
18. Combined Transcriptome and Proteome Profiling for Role of pfEMP1 in Antimalarial Mechanism of Action of Dihydroartemisinin.
Chen L; Zheng Z; Liu H; Wang X; Qu S; Yang Y; Deng S; Zhang Y; Tuo L; Zhao Y; Li Y
Microbiol Spectr; 2021 Dec; 9(3):e0127821. PubMed ID: 34908430
[TBL] [Abstract][Full Text] [Related]
19. The activity of proguanil and its metabolites, cycloguanil and p-chlorophenylbiguanide, against Plasmodium falciparum in vitro.
Watkins WM; Sixsmith DG; Chulay JD
Ann Trop Med Parasitol; 1984 Jun; 78(3):273-8. PubMed ID: 6385887
[TBL] [Abstract][Full Text] [Related]
20. Superoxide: A major role in the mechanism of action of essential antimalarial drugs.
Egwu CO; Tsamesidis I; Pério P; Augereau JM; Benoit-Vical F; Reybier K
Free Radic Biol Med; 2021 May; 167():271-275. PubMed ID: 33722628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
